Featured Presentations RGX-202 Topline Pivotal Results Corporate Presentation Data Publications March 2026: RGX-202 Oral Presentation At The Muscular Dystrophy Association Clinical & Scientific Conference 1.7 MB March 2026: RGX-202 Poster Presentation At The Muscular Dystrophy Association Clinical & Scientific Conference 16.5 MB October 2025: RGX-202 Poster Presentation at World Muscle Society Annual Congress 336.1 KB October 2025: RGX-202 Oral Presentation at World Muscle Society Annual Congress 594.2 KB August 2025: 2-Year Sura-vec (ABBV-RGX-314) Results in Non-Proliferative Diabetic Retinopathy 601.3 KB June 2025: RGX-202: Affinity Duchenne® New Phase I/II Interim Functional Data 1.2 MB November 2024 RGX-202: AFFINITY DUCHENNE® Pivotal Trial And Interim Functional Data 2.1 MB Upcoming Events May 26, 2026 at 9:30 AM EDT Stifel 2026 Virtual Ophthalmology Forum Add to Outlook Add to Google Calendar Past Events More events are coming soon.
March 2026: RGX-202 Oral Presentation At The Muscular Dystrophy Association Clinical & Scientific Conference 1.7 MB
March 2026: RGX-202 Oral Presentation At The Muscular Dystrophy Association Clinical & Scientific Conference 1.7 MB
March 2026: RGX-202 Poster Presentation At The Muscular Dystrophy Association Clinical & Scientific Conference 16.5 MB
March 2026: RGX-202 Poster Presentation At The Muscular Dystrophy Association Clinical & Scientific Conference 16.5 MB
August 2025: 2-Year Sura-vec (ABBV-RGX-314) Results in Non-Proliferative Diabetic Retinopathy 601.3 KB
August 2025: 2-Year Sura-vec (ABBV-RGX-314) Results in Non-Proliferative Diabetic Retinopathy 601.3 KB
May 26, 2026 at 9:30 AM EDT Stifel 2026 Virtual Ophthalmology Forum Add to Outlook Add to Google Calendar
